GRI Bio (GRI) Change in Accured Expenses (2020 - 2026)

GRI Bio's Change in Accured Expenses history runs 7 years deep, the most recent figure standing at -$317000.0 for Q1 2026.

• In Q1 2026, Change in Accured Expenses fell 156.41% year-over-year to -$317000.0; the TTM figure through Mar 2026 stood at -$820000.0 (down 421.57% YoY), while the FY2025 annual figure was $59000.0, up 112.32% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$317000.0, up from -$638000.0 in the prior quarter.
• The five-year high for Change in Accured Expenses was $1.2 million in Q2 2023, with the low at -$981000.0 in Q4 2023.
• The 5-year median for Change in Accured Expenses is -$51000.0 (2023), against an average of $4941.2.
• The sharpest annual moves came in 2023 and 2025: Change in Accured Expenses slumped 1025.47% in 2023, then surged 426.74% in 2025.
• GRI Bio's Change in Accured Expenses stood at $106000.0 in 2022, then plunged by 1025.47% to -$981000.0 in 2023, then soared by 116.31% to $160000.0 in 2024, then sank by 498.75% to -$638000.0 in 2025, then jumped by 50.31% to -$317000.0 in 2026.
• Business Quant data shows GRI's Change in Accured Expenses at -$317000.0 in Q1 2026, -$638000.0 in Q4 2025, and $428000.0 in Q3 2025.